IFNG and lung cancer: Based on the IFNγ release assay results, we postulate that the prophylactic vaccine derived from the KPL 160302S cell line may confer protection against lung cancer in KrasLSL-G12D/+/p53LSL-R172H/+ mice, potentially attributed to the generation of immune memory cells elicited by two novel antigens, Ddx21MT and Zfp760MT.